Conference Call with Divi's Laboratories Management and Analysts on Q2FY23 Performance and Outlook. Listen to the full earnings transcript.
Divi's Laboratories announced Q2FY23 results: Divi's Laboratories Limited (Divi's/the Company) has earned a consolidated total income of Rs 1,935 crore for Q2FY23 as against a consolidated total income of Rs 2,007 crore in the corresponding Q2FY22 Profit before tax (PBT) for Q2FY23 amounted to Rs 615 crore as against a PBT of Rs 760 crore for the corresponding Q2FY22 Profit after tax (PAT) for Q2FY23 amounted to Rs 494 crore as against a PAT of Rs 606 crore for Q2FY22 For Q2FY23, we have a forex gain of Rs 31 crore as against a loss of Rs 7 crore during Q2FY22. For H1FY23, the company earned a consolidated total income of Rs 4,278 crore as against a consolidated total income of Rs 3,996 crore during H1FY22 PAT for H1FY23 to Rs 1,196 crore as against Rs 1,164 crore for the previous H1FY22. For H1FY23, we had a forex gain of Rs 87 crore as against a gain of Rs 13 crore during the corresponding H1FY22. Result PDF